Advanced Search

Gastroenterology Coding Alert

You Be the Coder:

Botox Can Mean Reimbursement When Used as a Chemodenervating Agent

Published on Mon Aug 13, 2012

Question: Our gastroenterologist has recently begun using Botox in patients who are seen for strictures of the esophagus, gastroparesis, achalasia and such conditions. I need to know if Medicare and other insurance companies cover such a treatment using Botox. Colorado Subscriber Answer: Medicare and other insurance carriers will not cover Botox if it is used for any cosmetic reasons without any medical necessity apart from improving one's esthetic appearance. But if Botox is used for a purpose as mentioned by you in the treatment of a condition like achalasia, gastroparesis or to relieve strictures in the esophagus using forms of Botox injections such as Botox A or Botox R, you can receive reimbursements from Medicare and other insurance payers. By using Botox, your gastroenterologist is trying to cause a process known as chemodenervation that will help in inducing paralysis of the muscle. Since there is no definite CPT® code for [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Gastroenterology Coding Alert

View All